Keybank National Association OH Lowers Stake in GE HealthCare Technologies Inc. $GEHC

Keybank National Association OH cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 905,518 shares of the company’s stock after selling 32,328 shares during the quarter. Keybank National Association OH’s holdings in GE HealthCare Technologies were worth $68,005,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Allianz SE raised its holdings in GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. grew its position in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares during the last quarter. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Gladwyn Financial Advisors Inc. bought a new position in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $34,000. Finally, Piscataqua Savings Bank lifted its position in GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after acquiring an additional 300 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.2%

GE HealthCare Technologies stock opened at $78.97 on Friday. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock has a market cap of $35.97 billion, a PE ratio of 16.32, a P/E/G ratio of 2.38 and a beta of 1.08. The stock’s fifty day moving average is $82.63 and its two-hundred day moving average is $77.35.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 earnings per share. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

Analyst Ratings Changes

Several analysts have recently commented on GEHC shares. Stifel Nicolaus increased their price objective on GE HealthCare Technologies from $90.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, January 7th. Piper Sandler lifted their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their target price for the company from $73.00 to $77.00 in a report on Thursday, January 15th. Wells Fargo & Company reduced their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. Finally, Evercore ISI reiterated an “outperform” rating and issued a $95.00 price objective on shares of GE HealthCare Technologies in a report on Monday, January 5th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $90.33.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.